학술논문
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy
Document Type
Article
Author
Wykoff, Charles C.; Nittala, Muneeswar G.; Zhou, Brenda; Fan, Wenying; Velaga, Swetha Bindu; Lampen, Shaun I.R.; Rusakevich, Alexander M.; Ehlers, Justis P.; Babiuch, Amy; Brown, David M.; Ip, Michael S.; Sadda, SriniVas R.; Wykoff, Charles C.; Nittala, Muneeswar G.; Zhou, Brenda; Fan, Wenying; Velaga, Swetha Bindu; Rusakevich, Alexander M.; Lampen, Shaun I.R.; Ip, Michael S.; Sadda, SriniVas R.; Ehlers, Justis P.; Srivastava, Sunil K.; Reese, Jamie L.; Babiuch, Amy; Talcott, Katherine; Figueiredo, Natalia; Hach, Jenna; Ou, William C.; Fish, Richard H.; Benz, Matthew S.; Chen, Eric; Kim, Rosa Y.; Major, James C.; O’Malley, Ronan E.; Brown, David M.; Shah, Ankoor R.; Schefler, Amy C.; Wong, Tien P.; Henry, Christopher R.
Source
Ophthalmology Retina; December 2019, Vol. 3 Issue: 12 p1076-1086, 11p
Subject
Language
ISSN
24687219; 24686530
Abstract
Evaluate the impact of intravitreal aflibercept (Eylea; Regeneron, Tarrytown, NY) on retinal nonperfusion (RNP) in eyes with proliferative diabetic retinopathy (PDR).